Axcella Health Inc. (AXLA:NASDAQ) shot up at $0.6, a gain of 38.3%. On Tue, Jan 24, 2023, AXLA:NASDAQ hit a New 2-Week High of $0.6. The stock appeared on our News Catalysts scanner on Mon, Jan 23, 2023 at 04:54 PM in the 'MISCELLANEOUS' category. From Tue, Jan 10, 2023, the stock recorded 44.44% Up Days and 20.00% Green Days
The stock spiked on Tue, Jan 24, 2023 at $0.75 with a volume of 22M+.
About Axcella Health Inc. (AXLA:NASDAQ)
Axcella Health Inc a biotechnology company involved in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism. Its AXA candidates are generated from its proprietary, human-focused AXA Development Platform and harness the power of endogenous metabolic modulators, or EMMs. The company's pipeline comprises of five programs focused on the metabolic functions of the liver, muscle and blood.
Top 10 Gainers:
- bioAffinity Technologies Inc. (BIAF:NASDAQ), 74.38%
- Grom Social Enterprises Inc. (GROM:NASDAQ), 44.14%
- Axcella Health Inc. (AXLA:NASDAQ), 38.31%
- Baudax Bio, Inc. (BXRX:NASDAQ), 32.38%
- ContraFect Corporation (CFRX:NASDAQ), 31.24%
- Sotherly Hotels Inc. (SOHO:NASDAQ), 23.4%
- Bit Brother Limited (BTB:NASDAQ), 23.08%
- IronNet Inc. (IRNT:NYSE), 22.58%
- PyroGenesis (PYR:NASDAQ), 22.34%
- Vincerx Pharma Inc. (VINC:NASDAQ), 22.22%